Antibody-PET imaging might be of value for the selection of radioimmunotherapy (RIT) candidates to confirm tumor targeting and to estimate radiation doses to tumor and normal tissues. One of the requirements to be set for such a scouting procedure is that the biodistributions of the diagnostic and therapeutic radioimmunoconjugates should be similar. In the present study we evaluated the potential of the positron emitters zirconium-89 ((89)Zr) and iodine-124 ((124)I) for this approach, as these radionuclides have a relatively long half-life that matches with the kinetics of MAbs in vivo (t(1/2) 3.27 and 4.18 days, respectively). After radiolabeling of the head and neck squamous cell carcinoma (HNSCC)-selective chimeric antibody (cMAb) U36, t...
INTRODUCTION: With the introduction of positron-emitting radionuclides with half-lifes in days, such...
Positron emission tomography (PET) with 89Zr-labeled monoclonal antibodies (mAbs) or other targeted ...
The recent advances in the production of engineered antibodies have facilitated the development and ...
Item does not contain fulltextAntibody-PET imaging might be of value for the selection of radioimmun...
Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at the confirmation of tumor...
Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at the confirmation of tumor...
Immuno-PET as a scouting procedure before radioimmuno-therapy (RIT) aims at confirming tumor targeti...
Immuno-PET is an appealing concept in the detection of tumors and planning of antibody-based therapy...
PURPOSE: The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus associated (La)/S...
Targeted therapies hold great promise for cancer treatment and may exhibit even greater efficacy whe...
Selection of the right drug for the right patient is a promising approach to increase clinical benef...
Antibody based positron emission tomography (immuno-PET) imaging is of increasing importance to visu...
Immunotherapy has improved the survival of patients with advanced stages of various cancers, however...
© 2018 Dr. Stacey Erin RuddPositron emission tomography (PET) is a medical diagnostic imaging techni...
Positron emission tomography (PET) is an attractive imaging tool to localize and quantify tracer bio...
INTRODUCTION: With the introduction of positron-emitting radionuclides with half-lifes in days, such...
Positron emission tomography (PET) with 89Zr-labeled monoclonal antibodies (mAbs) or other targeted ...
The recent advances in the production of engineered antibodies have facilitated the development and ...
Item does not contain fulltextAntibody-PET imaging might be of value for the selection of radioimmun...
Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at the confirmation of tumor...
Immuno-PET as a scouting procedure before radioimmunotherapy (RIT) aims at the confirmation of tumor...
Immuno-PET as a scouting procedure before radioimmuno-therapy (RIT) aims at confirming tumor targeti...
Immuno-PET is an appealing concept in the detection of tumors and planning of antibody-based therapy...
PURPOSE: The chimeric monoclonal antibody (mAb) chDAB4 (APOMAB®) targets the Lupus associated (La)/S...
Targeted therapies hold great promise for cancer treatment and may exhibit even greater efficacy whe...
Selection of the right drug for the right patient is a promising approach to increase clinical benef...
Antibody based positron emission tomography (immuno-PET) imaging is of increasing importance to visu...
Immunotherapy has improved the survival of patients with advanced stages of various cancers, however...
© 2018 Dr. Stacey Erin RuddPositron emission tomography (PET) is a medical diagnostic imaging techni...
Positron emission tomography (PET) is an attractive imaging tool to localize and quantify tracer bio...
INTRODUCTION: With the introduction of positron-emitting radionuclides with half-lifes in days, such...
Positron emission tomography (PET) with 89Zr-labeled monoclonal antibodies (mAbs) or other targeted ...
The recent advances in the production of engineered antibodies have facilitated the development and ...